Human Leukocyte Antigen (HLA) is a type of molecule residing on the surfaces of most human cells and exerts an essential role in the immune system responding to the invasive items. The T cell antigen receptors may recognize the HLA-peptide complexes on the surfaces of cancer cells and destroy these cancer cells through toxic T lymphocytes. The computational determination of HLA-binding peptides will facilitate the rapid development of cancer immunotherapies. This study hypothesized that the natural language processing-encoded peptide features may be further enriched by another deep neural network. The hypothesis was tested with the Bi-directional Long Short-Term Memory-extracted features from the pretrained Protein Bidirectional Encoder Representations from Transformers-encoded features of the class I HLA (HLA-I)-binding peptides. The experimental data showed that our proposed HLAB feature engineering algorithm outperformed the existing ones in detecting the HLA-I-binding peptides. The extensive evaluation data show that the proposed HLAB algorithm outperforms all the seven existing studies on predicting the peptides binding to the HLA-A*01:01 allele in AUC and achieves the best average AUC values on the six out of the seven k-mers (k=8,9,...,14, respectively represent the prediction task of a polypeptide consisting of k amino acids) except for the 9-mer prediction tasks. The source code and the fine-tuned feature extraction models are available at http://www.healthinformaticslab.org/supp/resources.php.
2 January 2021 in Biological Trace Element Research
Drug repositioning, which involves identifying new therapeutic indications for approved drugs, is pivotal in accelerating drug discovery. Recently, to mitigate the effect of label sparsity on inferring potential drug–disease associations (DDAs), graph contrastive learning (GCL) has emerged as a promising paradigm to supplement high-quality self-supervised signals through designing auxiliary tasks, then transfer shareable knowledge to main task, i.e. DDA prediction. However, existing approaches still encounter two limitations. The first is how to generate augmented views for fully capturing higher-order interaction semantics. The second is the optimization imbalance issue between auxiliary and main tasks. In this paper, we propose a novel heterogeneous Graph Contrastive learning method with Gradient Balance for DDA prediction, namely GCGB. To handle the first challenge, a fusion view is introduced to integrate both semantic views (drug and disease similarity networks) and interaction view (heterogeneous biomedical network). Next, inter-view contrastive learning auxiliary tasks are designed to contrast the fusion view with semantic and interaction views, respectively. For the second challenge, we adaptively adjust the gradient of GCL auxiliary tasks from the perspective of gradient direction and magnitude for better guiding parameter update toward main task. Extensive experiments conducted on three benchmarks under 10-fold cross-validation demonstrate the model effectiveness.
Enhancers are short genomic regions exerting tissue-specific regulatory roles, usually for remote coding regions. Enhancers are observed in both prokaryotic and eukaryotic genomes, and their detections facilitate a better understanding of the transcriptional regulation mechanism. The accurate detection and transcriptional regulation strength evaluation of the enhancers remain a major bioinformatics challenge. Most of the current studies utilized the statistical features of short fixed-length nucleotide sequences. This study introduces the location information of each k-mer (SeqPose) into the encoding strategy of a DNA sequence and employs the attention mechanism in the two-layer bi-directional long-short term memory (BD-LSTM) model (spEnhancer) for the enhancer detection problem. The first layer of the delivered classifier discriminates between enhancers and non-enhancers, and the second layer evaluates the transcriptional regulation strength of the detected enhancer. The SeqPose-encoded features are selected by the Chi-squared test, and 45 positions are removed from further analysis. The existing studies may focus on selecting the statistical DNA sequence descriptors with large contributions to the prediction models. This study does not utilize these statistical DNA sequence descriptors. Then the word vector of the SeqPose-encoded features is obtained by using the word embedding layer. This study hypothesizes that different word vector features may contribute differently to the enhancer detection model, and assigns different weights to these word vectors through the attention mechanism in the BD-LSTM model. The previous study generously provided the training and independent test datasets, and the proposed spEnhancer is compared with the three existing state-of-the-art studies using the same experimental procedure. The leave-one-out validation data on the training dataset shows that the proposed spEnhancer achieves similar detection performances as the three existing studies. While spEnhancer achieves the best overall performance metric MCC for both of the two binary classification problems on the independent test dataset. The experimental data shows that the strategy of removing redundant positions (SeqPose) may help improve the DNA sequence-based prediction models. spEnhancer may serve well as a complementary model to the existing studies, especially for the novel query enhancers that are not included in the training dataset.
10 April 2025 in IEEE Journal of Biomedical and Health Informatics
Drug repositioning, which identifies new therapeutic potential of approved drugs, is instrumental in accelerating drug discovery. Recently, to alleviate the effect of data sparsity on predicting possible drug-disease associations (DDAs), graph contrastive learning (GCL) has emerged as a promising paradigm for learning discriminative representations of drugs and diseases through distilling informative self-supervised signals. However, existing GCLbased methods devised for DDA prediction still encounter two limitations. Firstly, the crucial heterogeneous property, which allows for capturing nuanced interaction semantics between biological entities, is overlooked. The second is how to perform contrastive view augmentation without relying on stochastic perturbation. In this study, we propose a novel multi-view contrastive learning approach for DDA prediction, namely MICLE. To handle the first issue, proteinrelated bipartite graphs are integrated with the original DDA network in advance, thereby composing a heterogeneous biological network (HBN). Besides, heterogeneous graph neural network is applied to mine the rich connectivity patterns implicit in the above HBN. For the second limitation, we design the complementary inter-view and intra-view contrastive learning tasks. Specifically, the former ensures that the mutual information between paired nodes across views is maximized, the latter enhances the agreement between each node and its first-order neighbors on similarity networks. Extensive experiments conducted on three benchmarks under 10-fold cross-validation demonstrate the model effectiveness. Source code and datasets are available at https://github.com/OleCui/paper MICLE.